Biora Therapeutics (BIOR) said Friday its board has approved a 1-for-10 reverse stock split as well as a reduction in the total number of authorized common shares to 255 million from 300 million.
The reverse split will take effect on Oct. 18, when the stock will begin trading on a split-adjusted basis at market open, the company said.
Biora Therapeutics shares were down 6.7% in recent trading.
Price: 0.52, Change: -0.04, Percent Change: -6.67
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments